3D Global Biotech Inc. (TPEX:6808)
Taiwan
· Delayed Price · Currency is TWD 60.00
+2.50 (4.35%)
Feb 21, 2025, 1:34 PM CST
3D Global Biotech Revenue
3D Global Biotech had revenue of 43.67M TWD in the half year ending June 30, 2024, with 585.69% growth. This brings the company's revenue in the last twelve months to 55.15M, up 235.81% year-over-year. In the year 2023, 3D Global Biotech had annual revenue of 20.63M with 51.24% growth.
Revenue (ttm)
55.15M
Revenue Growth
+235.81%
P/S Ratio
65.69
Revenue / Employee
1.67M
Employees
33
Market Cap
4.70B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 8.32B |
| Caliway Biopharmaceuticals | 44.43M |
| Bora Pharmaceuticals Co., LTD. | 16.71B |
| Lotus Pharmaceutical | 17.59B |
| Lumosa Therapeutics | 37.82M |
| Oneness Biotech | 112.20M |
| Polaris Group | 75.65M |
| Pegavision | 7.06B |